By Mariam Sunny April 22 (Reuters) - A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot ...
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...
By Ahmed Aboulenein and Sneha S K WASHINGTON, April 23 (Reuters) - U.S. health regulators announced a new program to speed up ...
The law would amend the Social Security Act, which governs both Medicare and Medicaid.
Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.
The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting ...
New legislation aims to make post-acute care services more accessible and streamline prior authorization approval in Medicare ...
Medicare Part B costs will rise in 2026. Here's what to expect, including higher prescription drug prices and payment changes ...
2don MSN
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for ...
The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dollars through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results